APO C200 (Carbamazepine extended-release 200 mg)

Pill imprint APO C200 has been identified as Carbamazepine extended-release 200 mg.

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; epilepsy; schizoaffective disorder; cluster-tic syndrome (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO C200

Carbamazepine extended-release 200 mg APO C200
Carbamazepine extended-release 200 mg APO C200
Carbamazepine extended-release
Imprint:
APO
C200
Strength:
200 mg
Color:
White / Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)